Loading viewer...
investor_presentation
Format: PDF investor_presentation
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing genetically targeted therapies for alcohol use disorder. The company is advancing Phase 3 clinical programs aimed at driving innovation in addiction treatment and addressing unmet medical needs in alcohol addiction prevention and management.
investor_presentation
56 Pages
Kinder Morgan
Investor Presentation
investor_presentationinvestor_presentation
SenSen Networks Limited
FS Credit Opportunities Corp. FSCO November 2022 IPO Presentation
investor_presentationinvestor_presentation
28 Pages
FS Credit Opportunities Corp.